TY - JOUR
T1 - Nutritional trials using high protein strategies and long duration of support show strongest clinical effects on mortality.
T2 - Results of an updated systematic review and meta-analysis
AU - Kaegi-Braun, Nina
AU - Faessli, Montserrat
AU - Kilchoer, Fiona
AU - Dragusha, Saranda
AU - Tribolet, Pascal
AU - Gomes, Filomena
AU - Bretscher, Céline
AU - Germann, Sara
AU - Deutz, Nicolaas E.
AU - Stanga, Zeno
AU - Mueller, Beat
AU - Schuetz, Philipp
N1 - Funding Information:
This study was supported in part by the Swiss National Science Foundation (SNSF Professorship , PP00P3_150531/1 ) and the Research Council of the Kantonsspital Aarau ( 1410.000.044 ).
Funding Information:
The Institution of P.Schuetz has previously received unrestricted grant money unrelated to this project from Nestlé Health Science and Abbott Nutrition. The institution of Z.Stanga received speaking honoraria and research support from Nestlé Health Science, Abbott Nutrition and Fresenius Kabi. Dr. Deutz reported grants from Abbot Nutrition, Department of Defense and National Institutes of Health. All other authors report no conflicts of interest. All other authors confirm that they do not have a conflict of interest associated with this manuscript.
Publisher Copyright:
© 2021 European Society for Clinical Nutrition and Metabolism
PY - 2021/10
Y1 - 2021/10
N2 - Background: There is increasing evidence from randomized-controlled trials demonstrating that nutritional support improves clinical outcomes in the population of malnourished medical inpatients. We investigated associations of trial characteristics including clinical setting, duration of intervention, individualization of nutritional support and amount of energy and protein, and effects on clinical outcomes in an updated meta-analysis. Methods: We searched Cochrane Library, MEDLINE and EMBASE, from inception to December 15, 2020. Randomized-controlled trials investigating the effect of oral and enteral nutritional support interventions, when compared to usual care, on clinical outcomes of malnourished non-critically ill medical inpatients were included. Two reviewers independently extracted data and assessed risk of bias. The primary endpoint was all cause-mortality within 12-months. Results: We included 29 randomized-controlled trials with a total of 7,166 patients. Heterogeneity across RCTs was high, with overall moderate study quality and mostly moderate or unclear risk of bias. Overall, there was an almost 30%-reduction in mortality in patients receiving nutritional support compared to patients not receiving nutritional support (253/2960 [8.5%] vs. 336/2976 [11.3%]) with an odds ratio of 0.72 (95% CI 0.57 to 0.91, p = 0.006). The most important predictors for the effect of nutritional trials on mortality were high protein strategies (odds ratio 0.57 vs. 0.93, I2 = 86.3%, p for heterogenity = 0.007) and long-term nutritional interventions (odds ratio 0.53 vs. 0.85, I2 = 76.2%, p for heterogenity = 0.040). Nutritional support also reduced unplanned hospital readmissions and length of hospital stay. Conclusions: There is increasing evidence from randomized trials showing that nutritional support significantly reduces mortality, unplanned hospital readmissions and length of stay in medical inpatients at nutritional risk, despite heterogeneity and varying methodological quality among trials. Trials with high-protein strategies and long-lasting nutritional support interventions were most effective.
AB - Background: There is increasing evidence from randomized-controlled trials demonstrating that nutritional support improves clinical outcomes in the population of malnourished medical inpatients. We investigated associations of trial characteristics including clinical setting, duration of intervention, individualization of nutritional support and amount of energy and protein, and effects on clinical outcomes in an updated meta-analysis. Methods: We searched Cochrane Library, MEDLINE and EMBASE, from inception to December 15, 2020. Randomized-controlled trials investigating the effect of oral and enteral nutritional support interventions, when compared to usual care, on clinical outcomes of malnourished non-critically ill medical inpatients were included. Two reviewers independently extracted data and assessed risk of bias. The primary endpoint was all cause-mortality within 12-months. Results: We included 29 randomized-controlled trials with a total of 7,166 patients. Heterogeneity across RCTs was high, with overall moderate study quality and mostly moderate or unclear risk of bias. Overall, there was an almost 30%-reduction in mortality in patients receiving nutritional support compared to patients not receiving nutritional support (253/2960 [8.5%] vs. 336/2976 [11.3%]) with an odds ratio of 0.72 (95% CI 0.57 to 0.91, p = 0.006). The most important predictors for the effect of nutritional trials on mortality were high protein strategies (odds ratio 0.57 vs. 0.93, I2 = 86.3%, p for heterogenity = 0.007) and long-term nutritional interventions (odds ratio 0.53 vs. 0.85, I2 = 76.2%, p for heterogenity = 0.040). Nutritional support also reduced unplanned hospital readmissions and length of hospital stay. Conclusions: There is increasing evidence from randomized trials showing that nutritional support significantly reduces mortality, unplanned hospital readmissions and length of stay in medical inpatients at nutritional risk, despite heterogeneity and varying methodological quality among trials. Trials with high-protein strategies and long-lasting nutritional support interventions were most effective.
KW - Metaanalysis
KW - Mortality
KW - Nutritional therapy
KW - Protein
KW - Trial
UR - http://www.scopus.com/inward/record.url?scp=85113876829&partnerID=8YFLogxK
U2 - 10.1016/j.clnesp.2021.08.003
DO - 10.1016/j.clnesp.2021.08.003
M3 - Article
C2 - 34620354
AN - SCOPUS:85113876829
SN - 2405-4577
VL - 45
SP - 45
EP - 54
JO - Clinical Nutrition ESPEN
JF - Clinical Nutrition ESPEN
ER -